Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Double-dummy, Placebo-controlled Trial to Determine the Relative Effect of PM101 I.V. Versus Placebo on Hemodynamics in Healthy Adult Volunteers

NCT00502346 is registered in ClinicalTrials.gov with Prism Pharmaceuticals as lead sponsor.

NCT NCT00502346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00502346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Double-dummy, Placebo-controlled Trial to Determine the Relative Effect of PM101 I.V. Versus Placebo on Hemodynamics in Healthy Adult Volunteers
Lead sponsor
Prism Pharmaceuticals
Phase
Phase 1
Overall status
Completed
Start date
July 3, 2007
Completion date
November 2, 2007
Enrollment
342 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy